Invizyne Technologies INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
ExoZymes Chief Scientific Officer, Tyler Korman, reports transactions involving the purchase of company common stock.
Damien Perriman, Chief Commercial Officer of ExoZymes Inc., was granted restricted stock and stock options on April 1, 2026, as detailed in a Form 4 filing.
Form 4: ExoZymes Officer Acquires Shares
Damien Alan Perriman, Chief Commercial Officer of ExoZymes Inc., acquired 8,887 shares of common stock on April 1, 2026.
ExoZymes Inc. Vice President Paul Opgenorth acquired 3,999 shares of common stock on April 1, 2026, increasing his beneficial ownership.
Fouad Nawaz, VP-Finance at ExoZymes Inc., reported a transaction involving the acquisition of 5,999 shares of common stock.
Form 4: ExoZymes Officer Acquires Shares
ExoZymes Chief Scientific Officer Tyler Korman acquired 5,332 shares of common stock on April 1, 2026.
EXOZYMES Inc. CEO Michael Heltzen reported the acquisition of 1,040 shares of common stock at $10.22 per share, increasing his direct beneficial ownership to 10,628.8 shares, effective July 2, 2025.
Exozymes Inc. CEO Michael Heltzen was granted 235,817 stock options with an exercise price of $12.40, vesting over four years starting July 1, 2025.
Tyler Paz Korman, Vice President of Research at Exozymes Inc., acquired 2,990 shares of common stock at $12.54 per share, increasing his beneficial ownership to 725,291 shares.
Paul Hideo Opgenorth, Vice President of Development at Exozymes Inc., acquired 2,990 shares of common stock at $12.54 per share, increasing his direct beneficial ownership to 641,150 shares.
Fouad Nawaz, Vice President of Finance at EXOZYMES INC., reported the acquisition of 3,489 shares of common stock at a price of $12.54 per share.
Invizyne Technologies CEO Michael Heltzen purchased shares of the company's common stock in multiple open market transactions.
Invizyne Technologies CEO, Michael Heltzen, acquired 1,984 shares of common stock at a price of $11.10 per share on November 15, 2024.
Paul Hideo Opgenorth, Vice President of Development at Invizyne Technologies, acquired 2,344 shares of common stock at $6.4 per share on November 8, 2024.
MDB Capital Holdings, LLC acquired 122,657 shares of Invizyne Technologies Inc. at a price of $6.4 per share, increasing their total holdings to 3,931,133 shares.